Stocks · Health care · Medicinal Chemicals & Botanical Products

Definium Therapeutics, Inc.

DFTX Clue Score37
United States Fiscal year ends December CIK 0001813814 Results filed 6 Aug 2026

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
Carol A Vallone
18 Sep 2026
Director
Exercised, kept
1,086
$35.52
$38.57K
Andreas Krebs
18 Sep 2026
Director
Exercised, kept
1,629
$35.52
$57.86K

What was left out

Form 4 filings counted 46
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 17
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 3,579,600
History held since 19 Jan 2022